The Correlation Between Tissue Oxygenations Using NIRS and Clinical Outcomes in Very Preterm Infants.

Launched by THE FIRST HOSPITAL OF JILIN UNIVERSITY · Jun 26, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on understanding how measuring tissue oxygen levels in very premature infants can help predict health complications they might face after birth. The researchers will use a non-invasive method called near-infrared spectroscopy (NIRS), which is a safe way to monitor how well oxygen is being delivered to different parts of the body, like the brain and intestines. This is particularly important for infants born before 32 weeks of gestation, as they are at a higher risk for serious health issues, such as bleeding in the brain or problems in the intestines.

To participate in this study, infants need to be born at less than 32 weeks and start NIRS monitoring within 24 hours after birth, with consent from their parents. The goal of the trial is to collect important information that could help doctors intervene early and improve the health outcomes of these vulnerable babies. If your infant qualifies and you decide to participate, you can expect regular monitoring to track their oxygen levels and help doctors better understand how to care for them in those critical early days.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • (1) All infants born at \<32 weeks of gestation. (2) Register and start NIRS monitoring within 24 hours after birth; (3) Obtain the written consent of parents.
• Exclusion Criteria:
• • Potential sensor interference: Disorders of/nonkeratinized skin; Hydrops/anasarca; Severe jaundice; Chromosomal abnormality ；Severe congenital malformations； Parents refuse to participate